4295 articles
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved faricimab (Roche, Vabysmo), the first bispecific antibody to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO), for NHS patients in England.
In a recent survey, Western doctors blamed burnout and staff shortages for an increase in medical errors, while half of respondents said they had considered leaving their profession in the past three months.
Coming together for the first time, O=Mega23, the largest clinical conference and trade show for optometry in the Southern Hemisphere, and the fourth World Congress of Optometry will firmly plant Australian optometry on the world stage next year, say organisers.
Twelve years in the making, Vision Bus Aotearoa was officially launched on 10 June at a University of Auckland ceremony attended by Governor-General Dame Cindy Kiro.
Innovative 3D-printed eyewear designer Monoqool has released a new screw-free Slider series, including model Double Agent featured here. These soft-looking frames are so flexible and lightweight you almost forget you’re wearing them, said founder Allan Petersen. Distributed by Phoenix Eyewear.
A research project proposing a novel non-invasive method to measure intracranial pressure (ICP), in a safe and timely manner, has been awarded one of 17 Explorer Grants by New Zealand’s Health Research Council (HRC).
Ashvattha Therapeutics’ phase 1 trial of patient-administered subcutaneous doses of its anti-VEGF therapy have shown it to be safe and well tolerated in healthy subjects. “We are advancing this first-in-class therapy to enable patients the convenience of self-administration with an autoinjector up t
Australian researchers have found retinal pigment epithelial (RPE) cells appear to be particularly susceptible to harbouring Ebola and other viruses. Uveitis occurs in up to one-third of Ebola
Researchers from the National Eye Institute (NEI) have identified a novel genetic macular dystrophy, which is yet to be named. “Affected individuals had scotomas and changes in their maculas
Clinical trial results for Tepezza, the only thyroid eye disease (TED) treatment approved by the US Food and Drug Administration (FDA), have associated the drug with hyperglycaemia in 10% of
ZEISS ClearView Finished Single Vision lenses represent a milestone in optics and aesthetics of stock lenses
A West Australian (WA) research team is testing the eyes of 500 patients to investigate possible links between sleep apnoea and the development of glaucoma.